請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37341完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 吳美玲 | |
| dc.contributor.author | Yi-Wen Cheng | en |
| dc.contributor.author | 鄭憶雯 | zh_TW |
| dc.date.accessioned | 2021-06-13T15:24:57Z | - |
| dc.date.available | 2013-09-11 | |
| dc.date.copyright | 2008-09-11 | |
| dc.date.issued | 2008 | |
| dc.date.submitted | 2008-07-21 | |
| dc.identifier.citation | Anderson, N. G., Maller, J. L., Tonks, N. K., and Sturgill, T. W. (1990). Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature 343, 651-653.
Apffel, C. A., Arnason, B. G., and Peters, J. H. (1966). Induction of tumour immunity with tumour cells treated with iodoacetate. Nature 209, 694-696. Arcari, P., Martinelli, R., and Salvatore, F. (1984). The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res 12, 9179-9189. Arriagada, R., Bergman, B., Dunant, A., Le Chevalier, T., Pignon, J. P., and Vansteenkiste, J. (2004). Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350, 351-360. Arutyunova, E. I., Danshina, P. V., Domnina, L. V., Pleten, A. P., and Muronetz, V. I. (2003). Oxidation of glyceraldehyde-3-phosphate dehydrogenase enhances its binding to nucleic acids. Biochem Biophys Res Commun 307, 547-552. Azzoli, C. G., Park, B. J., Pao, W., Zakowski, M., and Kris, M. G. (2008). Molecularly tailored adjuvant chemotherapy for resected non-small cell lung cancer: a time for excitement and equipoise. J Thorac Oncol 3, 84-93. Beevers, H., and Simon, E. W. (1949). Effect of pH on the activity of some respiratory inhibitors. Nature 163, 408. Beisswenger, P. J., Howell, S. K., Smith, K., and Szwergold, B. S. (2003). Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochim Biophys Acta 1637, 98-106. Bickis, I. J., and Quastel, J. H. (1965). Effects of Metabolic Inhibitors on Energy Metabolism of Ehrlich Ascites Carcinoma Cells. Nature 205, 44-46. Biedermann, K. A., and Landolph, J. R. (1987). Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res 47, 3815-3823. Blons, H., Cote, J. F., Le Corre, D., Riquet, M., Fabre-Guilevin, E., Laurent-Puig, P., and Danel, C. (2006). Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation. Am J Surg Pathol 30, 1309-1315. Boffetta, P., and Nyberg, F. (2003). Contribution of environmental factors to cancer risk. Br Med Bull 68, 71-94. Bos, J. L. (1989). ras oncogenes in human cancer: a review. Cancer Res 49, 4682-4689. Brambilla, E., Travis, W. D., Colby, T. V., Corrin, B., and Shimosato, Y. (2001). The new World Health Organization classification of lung tumours. Eur Respir J 18, 1059-1068. Brownlee, M., Cerami, A., and Vlassara, H. (1988). Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318, 1315-1321. Brune, B., and Lapetina, E. G. (1996). Nitric oxide-induced covalent modification of glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase. Methods Enzymol 269, 400-407. Burke, J. R., Enghild, J. J., Martin, M. E., Jou, Y. S., Myers, R. M., Roses, A. D., Vance, J. M., and Strittmatter, W. J. (1996). Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 2, 347-350. Cain, K., Bratton, S. B., and Cohen, G. M. (2002). The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie 84, 203-214. Capella, G., Cronauer-Mitra, S., Pienado, M. A., and Perucho, M. (1991). Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environ Health Perspect 93, 125-131. Chang, W. H., Chen, C. H., and Lu, F. J. (2002). Different effects of baicalein, baicalin and wogonin on mitochondrial function, glutathione content and cell cycle progression in human hepatoma cell lines. Planta Med 68, 128-132. Chatterjee, S., Noack, H., Possel, H., Keilhoff, G., and Wolf, G. (1999). Glutathione levels in primary glial cultures: monochlorobimane provides evidence of cell type-specific distribution. Glia 27, 152-161. Chien, K. R., Sen, A., Reynolds, R., Chang, A., Kim, Y., Gunn, M. D., Buja, L. M., and Willerson, J. T. (1985). Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion. Correlation with the progression of cell injury. J Clin Invest 75, 1770-1780. Chuang, D. M., Hough, C., and Senatorov, V. V. (2005). Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu Rev Pharmacol Toxicol 45, 269-290. Colell, A., Ricci, J. E., Tait, S., Milasta, S., Maurer, U., Bouchier-Hayes, L., Fitzgerald, P., Guio-Carrion, A., Waterhouse, N. J., Li, C. W., et al. (2007). GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 129, 983-997. Cramer, T., Yamanishi, Y., Clausen, B. E., Forster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003). HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112, 645-657. Crespo, P., Xu, N., Simonds, W. F., and Gutkind, J. S. (1994). Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits. Nature 369, 418-420. Cuezva, J. M., Chen, G., Alonso, A. M., Isidoro, A., Misek, D. E., Hanash, S. M., and Beer, D. G. (2004). The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis 25, 1157-1163. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M. A., Lassota, P., and Traganos, F. (1992). Features of apoptotic cells measured by flow cytometry. Cytometry 13, 795-808. Du, Z. X., Wang, H. Q., Zhang, H. Y., and Gao, D. X. (2007). Involvement of glyceraldehyde-3-phosphate dehydrogenase in tumor necrosis factor-related apoptosis-inducing ligand-mediated death of thyroid cancer cells. Endocrinology 148, 4352-4361. Eberhard, D. A., Johnson, B. E., Amler, L. C., Goddard, A. D., Heldens, S. L., Herbst, R. S., Ince, W. L., Janne, P. A., Januario, T., Johnson, D. H., et al. (2005). Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol 23, 5900-5909. Eguchi, Y., Shimizu, S., and Tsujimoto, Y. (1997). Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 57, 1835-1840. Epner, D. E., Partin, A. W., Schalken, J. A., Isaacs, J. T., and Coffey, D. S. (1993). Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma. Cancer Res 53, 1995-1997. Epner, D. E., Sawa, A., and Isaacs, J. T. (1999). Glyceraldehyde-3-phosphate dehydrogenase expression during apoptosis and proliferation of rat ventral prostate. Biol Reprod 61, 687-691. Fahim, F. A., Esmat, A. Y., Mady, E. A., and Ibrahim, E. K. (2003). Antitumor activities of iodoacetate and dimethylsulphoxide against solid Ehrlich carcinoma growth in mice. Biol Res 36, 253-262. Faure, M., Voyno-Yasenetskaya, T. A., and Bourne, H. R. (1994). cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 269, 7851-7854. Freedman, V. H., and Shin, S. I. (1974). Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3, 355-359. Gallis, J. L., Tissier, P., Gin, H., and Beauvieux, M. C. (2007). Decrease in oxidative phosphorylation yield in presence of butyrate in perfused liver isolated from fed rats. BMC Physiol 7, 8. Garner, D. L., and Johnson, L. A. (1995). Viability assessment of mammalian sperm using SYBR-14 and propidium iodide. Biol Reprod 53, 276-284. Gong, Y., Cui, L., and Minuk, G. Y. (1996). Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28s-ribosomal RNA gene expression in human hepatocellular carcinoma. Hepatology 23, 734-737. Green, D. R., and Reed, J. C. (1998). Mitochondria and apoptosis. Science 281, 1309-1312. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54, 4855-4878. Grossi, F., Loprevite, M., Chiaramondia, M., Ceppa, P., Pera, C., Ratto, G. B., Serrano, J., Ferrara, G. B., Costa, R., Boni, L., and Ardizzoni, A. (2003). Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers. Eur J Cancer 39, 1242-1250. Gunn, M. D., Sen, A., Chang, A., Willerson, J. T., Buja, L. M., and Chien, K. R. (1985). Mechanisms of accumulation of arachidonic acid in cultured myocardial cells during ATP depletion. Am J Physiol 249, H1188-1194. Hall, P. A., McKee, P. H., Menage, H. D., Dover, R., and Lane, D. P. (1993). High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8, 203-207. Hara, M. R., Agrawal, N., Kim, S. F., Cascio, M. B., Fujimuro, M., Ozeki, Y., Takahashi, M., Cheah, J. H., Tankou, S. K., Hester, L. D., et al. (2005). S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 7, 665-674. Hartwell, L. (1992). Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71, 543-546. Henkart, P. A. (1996). ICE family proteases: mediators of all apoptotic cell death? Immunity 4, 195-201. Hirsch, F. R., Varella-Garcia, M., Bunn, P. A., Jr., Di Maria, M. V., Veve, R., Bremmes, R. M., Baron, A. E., Zeng, C., and Franklin, W. A. (2003). Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 21, 3798-3807. Hollstein, M., Shomer, B., Greenblatt, M., Soussi, T., Hovig, E., Montesano, R., and Harris, C. C. (1996). Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res 24, 141-146. Hurst, R. D., Azam, S., Hurst, A., and Clark, J. B. (2001). Nitric-oxide-induced inhibition of glyceraldehyde-3-phosphate dehydrogenase may mediate reduced endothelial cell monolayer integrity in an in vitro model blood-brain barrier. Brain Res 894, 181-188. Husgafvel-Pursiainen, K., Hackman, P., Ridanpaa, M., Anttila, S., Karjalainen, A., Partanen, T., Taikina-Aho, O., Heikkila, L., and Vainio, H. (1993). K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos. Int J Cancer 53, 250-256. Ishitani, R., Tanaka, M., Sunaga, K., Katsube, N., and Chuang, D. M. (1998). Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol Pharmacol 53, 701-707. Jemal, A., Chu, K. C., and Tarone, R. E. (2001). Recent trends in lung cancer mortality in the United States. J Natl Cancer Inst 93, 277-283. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., and Thun, M. J. (2007). Cancer statistics, 2007. CA Cancer J Clin 57, 43-66. Jemal, A., Thomas, A., Murray, T., and Thun, M. (2002). Cancer statistics, 2002. CA Cancer J Clin 52, 23-47. Jemal, A., Ward, E., and Thun, M. J. (2005). Contemporary lung cancer trends among U.S. women. Cancer Epidemiol Biomarkers Prev 14, 582-585. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597. Kato, M., Sakai, K., and Endo, A. (1992). Koningic acid (heptelidic acid) inhibition of glyceraldehyde-3-phosphate dehydrogenases from various sources. Biochim Biophys Acta 1120, 113-116. Keelan, J., Allen, N. J., Antcliffe, D., Pal, S., and Duchen, M. R. (2001). Quantitative imaging of glutathione in hippocampal neurons and glia in culture using monochlorobimane. J Neurosci Res 66, 873-884. Kosaka, T., Yatabe, Y., Endoh, H., Kuwano, H., Takahashi, T., and Mitsudomi, T. (2004). Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 64, 8919-8923. Kosower, N. S., and Kosower, E. M. (1987). Thiol labeling with bromobimanes. Methods Enzymol 143, 76-84. Kroemer, G., and Reed, J. C. (2000). Mitochondrial control of cell death. Nat Med 6, 513-519. Lane, D. P. (1992). Cancer. p53, guardian of the genome. Nature 358, 15-16. Le Calvez, F., Mukeria, A., Hunt, J. D., Kelm, O., Hung, R. J., Taniere, P., Brennan, P., Boffetta, P., Zaridze, D. G., and Hainaut, P. (2005). TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res 65, 5076-5083. Le, C. H., Ko, Y. C., Cheng, L. S., Lin, Y. C., Lin, H. J., Huang, M. S., Huang, J. J., Kao, E. L., and Wang, H. Z. (2001). The heterogeneity in risk factors of lung cancer and the difference of histologic distribution between genders in Taiwan. Cancer Causes Control 12, 289-300. Lemasters, J. J., DiGuiseppi, J., Nieminen, A. L., and Herman, B. (1987). Blebbing, free Ca2+ and mitochondrial membrane potential preceding cell death in hepatocytes. Nature 325, 78-81. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D. (1992). Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923-935. Lu, X., Park, S. H., Thompson, T. C., and Lane, D. P. (1992). Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation. Cell 70, 153-161. Malcolm, C. S., Benwell, K. R., Lamb, H., Bebbington, D., and Porter, R. H. (2000). Characterization of iodoacetate-mediated neurotoxicity in vitro using primary cultures of rat cerebellar granule cells. Free Radic Biol Med 28, 102-107. Manning, F. C., and Patierno, S. R. (1996). Apoptosis: inhibitor or instigator of carcinogenesis? Cancer Invest 14, 455-465. Mascaux, C., Iannino, N., Martin, B., Paesmans, M., Berghmans, T., Dusart, M., Haller, A., Lothaire, P., Meert, A. P., Noel, S., et al. (2005). The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 92, 131-139. Matrisian, L. M., Rautmann, G., Magun, B. E., and Breathnach, R. (1985). Epidermal growth factor or serum stimulation of rat fibroblasts induces an elevation in mRNA levels for lactate dehydrogenase and other glycolytic enzymes. Nucleic Acids Res 13, 711-726. Matthews, R. T., Ferrante, R. J., Jenkins, B. G., Browne, S. E., Goetz, K., Berger, S., Chen, I. Y., and Beal, M. F. (1997). Iodoacetate produces striatal excitotoxic lesions. J Neurochem 69, 285-289. Mazzola, J. L., and Sirover, M. A. (2002). Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders? Neurotoxicology 23, 603-609. Meldrum, D. R. (1998). Tumor necrosis factor in the heart. Am J Physiol 274, R577-595. Mills, N. E., Fishman, C. L., Rom, W. N., Dubin, N., and Jacobson, D. R. (1995). Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res 55, 1444-1447. Morgenegg, G., Winkler, G. C., Hubscher, U., Heizmann, C. W., Mous, J., and Kuenzle, C. C. (1986). Glyceraldehyde-3-phosphate dehydrogenase is a nonhistone protein and a possible activator of transcription in neurons. J Neurochem 47, 54-62. Nagy, E., and Rigby, W. F. (1995). Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold). J Biol Chem 270, 2755-2763. Nelson, H. H., Christiani, D. C., Mark, E. J., Wiencke, J. K., Wain, J. C., and Kelsey, K. T. (1999). Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 91, 2032-2038. Nicholson, R. I., Gee, J. M., and Harper, M. E. (2001). EGFR and cancer prognosis. Eur J Cancer 37 Suppl 4, S9-15. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., and Riccardi, C. (1991). A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139, 271-279. Nicotera, P., Leist, M., and Ferrando-May, E. (1998). Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett 102-103, 139-142. Ohsaki, Y., Tanno, S., Fujita, Y., Toyoshima, E., Fujiuchi, S., Nishigaki, Y., Ishida, S., Nagase, A., Miyokawa, N., Hirata, S., and Kikuchi, K. (2000). Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncol Rep 7, 603-607. Perez, R. P. (1998). Cellular and molecular determinants of cisplatin resistance. Eur J Cancer 34, 1535-1542. Putnam, E. A., Yen, N., Gallick, G. E., Steck, P. A., Fang, K., Akpakip, B., Gazdar, A. F., and Roth, J. A. (1992). Autocrine growth stimulation by transforming growth factor-alpha in human non-small cell lung cancer. Surg Oncol 1, 49-60. Riordan, J. T., Muthaiyan, A., Van Voorhies, W., Price, C. T., Graham, J. E., Wilkinson, B. J., and Gustafson, J. E. (2007). Response of Staphylococcus aureus to salicylate challenge. J Bacteriol 189, 220-227. Rondinelli, R. H., Epner, D. E., and Tricoli, J. V. (1997). Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in late pathological stage human prostate cancer. Prostate Cancer Prostatic Dis 1, 66-72. Sabri, M. I., and Ochs, S. (1971). Inhibition of glyceraldehyde-3-phosphate dehydrogenase in mammalian nerve by iodoacetic acid. J Neurochem 18, 1509-1514. Sakai, K., Hasumi, K., and Endo, A. (1990). Two glyceraldehyde-3-phosphate dehydrogenase isozymes from the koningic acid (heptelidic acid) producer Trichoderma koningii. Eur J Biochem 193, 195-202. Sakai, K., Hasumi, K., and Endo, A. (1991). Identification of koningic acid (heptelidic acid)-modified site in rabbit muscle glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1077, 192-196. Sakurai, K., and Cederbaum, A. I. (1998). Oxidative stress and cytotoxicity induced by ferric-nitrilotriacetate in HepG2 cells that express cytochrome P450 2E1. Mol Pharmacol 54, 1024-1035. Saunders, P. A., Chalecka-Franaszek, E., and Chuang, D. M. (1997). Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis. J Neurochem 69, 1820-1828. Sawa, A., Khan, A. A., Hester, L. D., and Snyder, S. H. (1997). Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci U S A 94, 11669-11674. Schiller, J. H. (2003). Platin or no platin? That is the question. J Clin Oncol 21, 3009-3010. Schultz, D. E., Hardin, C. C., and Lemon, S. M. (1996). Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5'-nontranslated RNA of hepatitis A virus. J Biol Chem 271, 14134-14142. Schulze, H., Schuler, A., Stuber, D., Dobeli, H., Langen, H., and Huber, G. (1993). Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's beta-amyloid precursor protein. J Neurochem 60, 1915-1922. Sharief, F. S., Mohler, J. L., Sharief, Y., and Li, S. S. (1994). Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues. Biochem Mol Biol Int 33, 567-574. Sharma, S. V., Bell, D. W., Settleman, J., and Haber, D. A. (2007). Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 7, 169-181. Shigematsu, H., Lin, L., Takahashi, T., Nomura, M., Suzuki, M., Wistuba, II, Fong, K. M., Lee, H., Toyooka, S., Shimizu, N., et al. (2005). Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97, 339-346. Singh, R., and Green, M. R. (1993). Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science 259, 365-368. Sirover, M. A. (1999). New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1432, 159-184. Sirover, M. A. (2005). New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells. J Cell Biochem 95, 45-52. Song, S., and Finkel, T. (2007). GAPDH and the search for alternative energy. Nat Cell Biol 9, 869-870. Stahel, R. A. (2007). Adenocarcinoma, a molecular perspective. Ann Oncol 18 Suppl 9, ix147-149. Sun, S., Schiller, J. H., and Gazdar, A. F. (2007). Lung cancer in never smokers--a different disease. Nat Rev Cancer 7, 778-790. Tajima, H., Tsuchiya, K., Yamada, M., Kondo, K., Katsube, N., and Ishitani, R. (1999). Over-expression of GAPDH induces apoptosis in COS-7 cells transfected with cloned GAPDH cDNAs. Neuroreport 10, 2029-2033. Tam, I. Y., Chung, L. P., Suen, W. S., Wang, E., Wong, M. C., Ho, K. K., Lam, W. K., Chiu, S. W., Girard, L., Minna, J. D., et al. (2006). Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin Cancer Res 12, 1647-1653. Tarze, A., Deniaud, A., Le Bras, M., Maillier, E., Molle, D., Larochette, N., Zamzami, N., Jan, G., Kroemer, G., and Brenner, C. (2007). GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene 26, 2606-2620. Tokunaga, K., Nakamura, Y., Sakata, K., Fujimori, K., Ohkubo, M., Sawada, K., and Sakiyama, S. (1987). Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 47, 5616-5619. van Gurp, M., Festjens, N., van Loo, G., Saelens, X., and Vandenabeele, P. (2003). Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun 304, 487-497. van Zandwijk, N. (1995). N-acetylcysteine (NAC) and glutathione (GSH): antioxidant and chemopreventive properties, with special reference to lung cancer. J Cell Biochem Suppl 22, 24-32. Velculescu, V. E., and El-Deiry, W. S. (1996). Biological and clinical importance of the p53 tumor suppressor gene. Clin Chem 42, 858-868. Verity, M. A., Torres, M., and Sarafian, T. (1991). Paradoxical potentiation by low extracellular Ca2+ of acute chemical anoxic neuronal injury in cerebellar granule cell culture. Mol Chem Neuropathol 15, 217-233. Vermes, I., Haanen, C., and Reutelingsperger, C. (2000). Flow cytometry of apoptotic cell death. J Immunol Methods 243, 167-190. Vila, M. R., Nicolas, A., Morote, J., de, I., and Meseguer, A. (2000). Increased glyceraldehyde-3-phosphate dehydrogenase expression in renal cell carcinoma identified by RNA-based, arbitrarily primed polymerase chain reaction. Cancer 89, 152-164. Warburg, O. (1956a). On the origin of cancer cells. Science 123, 309-314. Warburg, O. (1956b). [Origin of cancer cells.]. Oncologia 9, 75-83. Webb, J. L. (1950). The actions of metabolic substrates and inhibitors on the rabbit auricle. Br J Pharmacol Chemother 5, 87-117. Webb, J. L., Saunders, P. R., and Thienes, C. H. (1949). The metabolism of the heart in relation to drug action; the action of metabolic inhibitors on rat heart slice respiration. Arch Biochem 22, 458-466. Wells, A. (1999). EGF receptor. Int J Biochem Cell Biol 31, 637-643. Wolf, M. B., and Baynes, J. W. (2006). The anti-cancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunction. Biochim Biophys Acta 1760, 267-271. Yamaguchi, H., Bhalla, K., and Wang, H. G. (2003). Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria. Cancer Res 63, 1483-1489. Yang, Z., Faustino, P. J., Andrews, P. A., Monastra, R., Rasmussen, A. A., Ellison, C. D., and Cullen, K. J. (2000). Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines. Cancer Chemother Pharmacol 46, 255-262. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., and Wahl, G. M. (1992). Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70, 937-948. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37341 | - |
| dc.description.abstract | 肺癌目前乃是臨床上相當棘手之癌症，目前除使用外科手術及cytotoxic chemotherapy之外，即使用最新二種之EGFR tyrosine kinase inhibitors (Iressa或 Tarceva)，77% NSCLC病人短期內，有明顯腫瘤縮小反應，特別是對東亞非吸煙之女性有明顯療效。雖然立即藥效明顯，可惜目前臨床試驗用上述二種EGFR-TKI之最新結果，相當令人失望，因在使用約6-12月後，原來對TKI inhibitors有反應的病患會產生抗藥性。由以上簡述得知目前國內外對NSCLC以TKI inhibitors之最新治療仍陷入困境(Sharma et al., 2007)。本研究乃探討以iodoacetic acid (IAA)處理人類肺癌細胞株，探討IAA對肺癌細胞之生長影響及其作用機轉。目前已知，肺癌病人中之Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)基因表現有明顯上升，而IAA是GAPDH的抑制劑，而GAPDH除了扮演醣解作用裡的重要角色，GAPDH似乎扮演其他較少被了解的功能。本研究結果顯示，IAA可經由抑制人類肺癌(A549，NCI-HOP62，NCI-H23， NCI-EKVX，H522及H1299)細胞生長及促進凋亡之方式，造成對細胞的傷害。起先利用MTT與Hoechst螢光染色觀察，研究的結果顯示IAA對人類肺癌細胞的生長及分化會產生dose-dependent的毒性，然而利用免疫化學染色技術,我們可觀察到人類肺癌細胞在經過IAA處裡後，發生cytochrome c釋出及caspase活化及凋亡的比例增加。進一步實驗結果顯示經Hoechst染色後發現染色質有縮濃的現象、Annexin V(+)的螢光強度及細胞數目增加，由此可知，細胞死亡很可能是經由細胞凋亡所形成。為了進一步的研究IAA造成細胞凋亡的機制，由MCB螢光染色發現IAA會引起細胞內Glutathione( GSH )減少，並且IAA會引起細胞內ATP含量下降。另外，我們發現IAA會下降細胞的生長及細胞群落形成的能力。綜合我們的實驗結果，我們發現IAA會造成人類肺癌細胞的凋亡。對於IAA造成人類肺癌細胞的凋亡途徑的了解，將有助於提供治療目標，進而治療人類肺癌提升治療效果。 | zh_TW |
| dc.description.abstract | Lung cancer is very difficult to be cured even using target gene therapy. In East Asia’s non-smoking women Iressa and Tarceva, two newly developed EGRF tyrosine kinase inhibitor (EGFR TKIs), largely reduce the tumor size in 77% patients in a few weeks time. In most of the lung patients who treated with EGFR TKIs, however, it is very disappointing that the cancer is recurrent within 6-12 months with drug resistance (Sharma et al., 2007). Iodoacetic acid (IAA) is not only an inhibitor of GAPDH but also plays a crucial role in variety novel cellular functions. Using human lung cancer cell lines, I investigated possible mechanism(s) of IAA-induced cell death. My results showed that IAA induced dose-dependent cell death, including A549, NCI HOP62, NCI H23 NCI EKVX, H522 and H1299. I also found that IAA induced cytochrome c release, caspase-3 activation, and chromatin condensation in A549. Furthermore, IAA induced intracellular ATP and GSH depletion, and pretreatment with either NAC or DTT prevented IAA-induced cell death. In conclusion, my data demonstrated that IAA effectively induced cell death in at least six lung cancer cell lines. It might provide possible target therapy for future clinical use. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T15:24:57Z (GMT). No. of bitstreams: 1 ntu-97-R95441004-1.pdf: 1911642 bytes, checksum: d5b73023fad10c4298e1ec6da85ff8f7 (MD5) Previous issue date: 2008 | en |
| dc.description.tableofcontents | 圖次………………………………………………………………………VⅢ
表次……………………………………………………………………… IX 附錄………………………………………………………………………X 摘要……………………………………………………………………… IV Abstract……………………………………………………………………VI 緒論………………………………………………………………………1 材料與方法………………………………………………………………12 結果………………………………………………………………………20 討論………………………………………………………………………29 結論與展望………………………………………………………………36 表…………………………………………………………………………37 圖…………………………………………………………………………40 附錄………………………………………………………………………56 參考文獻…………………………………………………………………59 | |
| dc.language.iso | zh-TW | |
| dc.title | 碘乙酸(Iodoacetic acid)於人類肺癌細胞造成細胞凋亡機制之探討 | zh_TW |
| dc.title | Mechanism of Iodoacetic acid-Induced Apoptosis in Human Lung Cancer Cells | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 96-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 俞松良,胡孟君 | |
| dc.subject.keyword | 碘乙酸,肺癌,凋亡, | zh_TW |
| dc.subject.keyword | Iodoacetic acid,Lung Cancer,Apoptosis, | en |
| dc.relation.page | 71 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2008-07-21 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 生理學研究所 | zh_TW |
| 顯示於系所單位： | 生理學科所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-97-1.pdf 目前未授權公開取用 | 1.87 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。